Financial Advantage’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-200
Closed -$6K 137
2015
Q1
$6K Buy
+200
New +$6K 0.01% 108